0.27200001 EUR
0.012
4.23%
Last update Dec 15, 7:31 PM CET
Main market
Day range
0.27200001
0.31799999
Previous close
0.28400001
Open
0.28799999
Access this stock data via API
Subscribe
IGC Pharma Inc.
0.27
0.01
4.23%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2025 2024 2023 2022
Total reported revenue 1.1M 1.3M 911K 397K
Cost of revenue 555.3K 612K 469K 203K
Gross profit 527.2K 733K 442K 194K
Operating expense
Research & development 3.1M 3.8M 3.5M 2.3M
Selling general and admin 3.8M 6.8M 8.6M 13.3M
Other operating expenses
Operating income -6.3M -9.8M -11.6M -15.4M
Non operating interest income
Income
Expense
Other income expense 276.8K -3.2M 65K 412K
Pretax income -6.1M -13M -11.5M -15.0M
Tax provision 0 0 0 0
Net income -6.1M -13M -11.5M -15.0M
Basic EPS -0.1 -0.2 -0.2 -0.3
Diluted EPS -0.1 -0.2 -0.2 -0.3
Basic average shares 65.2M 58.8M 55.0M 52.3M
Diluted average shares 65.2M 58.8M 55.0M 52.3M
EBITDA -5.8M -5.8M -10.9M -14.7M
Net income from continuing op. -6.1M -13M -11.5M -15.0M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 17 minutes

11:42
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).